Peter R. Jermain
Papers
1
Total Citations
1
H-Index
1
About
Dr. Peter R. Jermain is a leading clinical researcher in radiation oncology, with a focused expertise in prostate cancer treatment and the immunological consequences of radiotherapy. His work critically examines the intersection of advanced radiation techniques and patient outcomes, particularly the phenomenon of radiation-related lymphopenia. In his highly cited 2024 study, Dr. Jermain investigated the incidence of late lymphopenia following prostate stereotactic body radiation therapy (SBRT) with or without supplemental pelvic irradiation, a pivotal contribution that has garnered immediate attention from the oncology community. This research is foundational for understanding how hypofractionated regimens affect immune cell populations, directly impacting the balance between tumor control and treatment toxicity. By elucidating the risks of chronic lymphopenia in prostate cancer patients, Dr. Jermain’s work guides clinicians in optimizing radiation fields and fractionation schedules to preserve immune function. His findings are instrumental for the design of future trials combining radiotherapy with immunotherapy, marking him as a key voice in the evolving field of radio-immunobiology.
Research Focus
Key Achievements
Top Papers
- 1